Evidence map›Paper›PMID 28818791›Full record

ArticleRedox biology2017

Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction.

Adrian I Abdo, Benjamin S Rayner, David M van Reyk, Clare L Hawkins

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Neutrophil extracellular traps: a catalyst for atherosclerosis.Molecular and cellular biochemistry · 2024
    Review
  5. Article
  6. Article
  7. Neutrophil counts and cardiovascular disease.European heart journal · 2023
    Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. The Role of Oxidative Stress in Acute Ischemic Stroke-Related Thrombosis.Oxidative medicine and cellular longevity · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Smoking and the Pathophysiology of Peripheral Artery Disease.Frontiers in cardiovascular medicine · 2021
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Adrian I AbdoThe Heart Research Institute, 7 Eliza St, Newtown, NSW 2042, Australia; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.
Benjamin S RaynerThe Heart Research Institute, 7 Eliza St, Newtown, NSW 2042, Australia; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.
David M van ReykSchool of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
Clare L HawkinsThe Heart Research Institute, 7 Eliza St, Newtown, NSW 2042, Australia; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia; Department of Biomedical Sciences, Panum Institute, University of Copenhagen, Blegdamsvej 3, Copenhagen N 2200, Denmark. Electronic address: clare.hawkins@sund.ku.dk.
University of Sydney · AUUniversity of Copenhagen · DKUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-density lipoprotein (LDL) modified by hypochlorous acid (HOCl) produced by myeloperoxidase (MPO) is present in atherosclerotic lesions, where it is implicated in the propagation of inflammation and acceleration of lesion development by multiple pathways, including the induction of endothelial dysfunction. Thiocyanate (SCN

Indexed as

AnimalsAortaCells, CulturedEndothelial CellsHypochlorous AcidLipoproteins, LDLMaleNitric OxideNitric Oxide Synthase Type IIIPeroxidaseRatsRats, Sprague-DawleyThiocyanatesVasodilationHypochlorous Acidhypothiocyanous acidLipoproteins, LDLNitric OxideNitric Oxide Synthase Type IIIPeroxidaseThiocyanatesAtherosclerosisEndothelial dysfunctionLow-density lipoproteinMyeloperoxidaseNitric oxide

Identifiers

PMID28818791
PMCPMC5558469
OpenAlexW2745305461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.